Materialise NV (MTLS) FinancialsMTLSMaterialise NV

Materialise NV (MTLS) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Materialise Medical, accounting for 50.0% of total sales, equivalent to €33.16M. Other significant revenue streams include Materialise Manufacturing and Materialise Software. Understanding this composition is critical for investors evaluating how MTLS navigates market cycles within the Software industry.

Evaluating the bottom line, Materialise NV maintains a gross margin of 56.77%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.97%, while the net margin is 4.75%. These profitability ratios, combined with a Return on Equity (ROE) of 5.22%, provide a clear picture of how effectively MTLS converts its operational activities into shareholder value.

In the context of the broader market, MTLS competes directly with industry leaders such as GRVY and NEXN. With a market capitalization of $486.51M, it holds a significant position in the sector. When comparing efficiency, MTLS's gross margin of 56.77% stands against GRVY's 32.33% and NEXN's 62.29%. Such benchmarking helps identify whether Materialise NV is trading at a premium or discount relative to its financial performance.

Materialise NV has shown a gross margin of 56.77% in Q2 2026, which is relatively strong, but the net income has fluctuated, with a reported net income of €3,332,000 in Q2 2026, indicating some recovery but also volatility.